| Scidose LLC Patent applications |
| Patent application number | Title | Published |
|---|
| 20110092580 | Docetaxel formulations with lipoic acid and/or dihydrolipoic acid - Formulations comprising docetaxel or a salt thereof in combination with α-lipoic acid and/or dihydrolipoic acid and/or salts thereof in narrow concentration ranges have improved stability as concentrate liquid formulations and permit longer times between dilution from higher concentrations through completion of infusions prepared therefrom allowing for lesser waste and more efficient use of personnel in infusion preparation. | 04-21-2011 |
| 20110092579 | Solubilized formulation of docetaxel - Docetaxel containing formulations having TPGS and being substantially free or totally free of polysorbate surfactants are disclosed wherein stability is enhanced and hypersensitivity reactions are reduced. | 04-21-2011 |
| 20100239669 | Combinations of statins and anti-obesity agent - Co-therapy of an anti-obesity agent, a statin, is disclosed along with fixed combinations thereof. Atorvastatin and orlistat are preferred as the various components. | 09-23-2010 |
| 20100234443 | Combinations of statins and anti-obesity agent - Co-therapy of an anti-obesity agent, a statin, is disclosed along with fixed combinations thereof. Atorvastatin and orlistat are preferred as the various components. | 09-16-2010 |
